New lung navigation system aims for precise nodule marking
NCT ID NCT07180823
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new navigation system called LungVision to help doctors mark suspicious lung nodules before surgery. The system uses augmented fluoroscopy and ultrasound to guide a small marker to the nodule. The goal is to make marking easier and less invasive than current methods, allowing surgeons to remove the nodule completely while saving healthy lung tissue. The study will include 5 adults with partially solid lung nodules.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LungVision navigation system (device)
What this could lead to
If successful, this could make lung nodule marking safer and more accurate, allowing surgeons to remove cancerous nodules with smaller incisions and preserve more healthy lung tissue.
What could go wrong
This is a very small early study with only 5 participants, so results may not apply to everyone. The procedure still carries risks like lung collapse or bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITINGBologna, Bologna, 40138, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••